Search research articles
Contact Us
Filters
Showing results (111-120 of 159) with videos related to
Page
of 16
Sort By:
Journal of Hypertension
|
December 3, 2019
Reply
Christopher R Gingles, Ruth Symon, Stephen J Gandy, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 6, 2002
Variation at the aldosterone synthase (CYP11B2) locus contributes to hypertension in subjects with a raised aldosterone-to-renin ratio
Pitt O Lim, Thomas M Macdonald, Christine Holloway, et al.
Antioxidants (Basel, Switzerland)
|
August 26, 2022
The Prognostic Value of Derivatives-Reactive Oxygen Metabolites (d-ROMs) for Cardiovascular Disease Events and Mortality: A Review
Filippo Pigazzani, Davide Gorni, Kenneth A Dyar, et al.
BMJ Open
|
August 9, 2015
Comparison of single and combination diuretics on glucose tolerance (PATHWAY-3): protocol for a randomised double-blind trial in patients with essential hypertension
Morris J Brown, Bryan Williams, Thomas M MacDonald, et al.
Drug Safety
|
February 19, 2021
Identification and Validation of Major Cardiovascular Events in the United Kingdom Data Sources Included in a Multi-database Post-authorization Safety Study of Prucalopride
Ana Ruigómez, Estel Plana, Alicia Gilsenan, et al.
Paediatric and Perinatal Epidemiology
|
July 17, 2004
The Walker Project: a longitudinal study of 48,000 children born 1952-1966 (aged 36-50 years in 2002) and their families
Gillian Libby, Anne Smith, Neil F McEwan, et al.
BMJ Open
|
August 9, 2015
Prevention And Treatment of Hypertension With Algorithm-based therapy (PATHWAY) number 2: protocol for a randomised crossover trial to determine optimal treatment for drug-resistant hypertension
Bryan Williams, Thomas M MacDonald, Mark Caulfield, et al.
BMJ Open
|
February 11, 2016
Methods of a large prospective, randomised, open-label, blinded end-point study comparing morning versus evening dosing in hypertensive patients: the Treatment In Morning versus Evening (TIME) study
David A Rorie, Amy Rogers, Isla S Mackenzie, et al.
BMC Medicine
|
February 3, 2021
Impact of multiple cardiovascular medications on mortality after an incidence of ischemic stroke or transient ischemic attack
Tian-Tian Ma, Ian C K Wong, Cate Whittlesea, et al.
BMC Medicine
|
September 12, 2021
Correction to: Impact of multiple cardiovascular medications on mortality after an incidence of ischemic stroke or transient ischemic attack
Tian-Tian Ma, Ian C K Wong, Cate Whittlesea, et al.
Page
of 16
Search research articles
Search
Showing results (111-120 of 159) with videos related to
Sort By:
Page
of 16
Journal of Hypertension
|
December 3, 2019
Reply
Christopher R Gingles, Ruth Symon, Stephen J Gandy, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 6, 2002
Variation at the aldosterone synthase (CYP11B2) locus contributes to hypertension in subjects with a raised aldosterone-to-renin ratio
Pitt O Lim, Thomas M Macdonald, Christine Holloway, et al.
Antioxidants (Basel, Switzerland)
|
August 26, 2022
The Prognostic Value of Derivatives-Reactive Oxygen Metabolites (d-ROMs) for Cardiovascular Disease Events and Mortality: A Review
Filippo Pigazzani, Davide Gorni, Kenneth A Dyar, et al.
BMJ Open
|
August 9, 2015
Comparison of single and combination diuretics on glucose tolerance (PATHWAY-3): protocol for a randomised double-blind trial in patients with essential hypertension
Morris J Brown, Bryan Williams, Thomas M MacDonald, et al.
Drug Safety
|
February 19, 2021
Identification and Validation of Major Cardiovascular Events in the United Kingdom Data Sources Included in a Multi-database Post-authorization Safety Study of Prucalopride
Ana Ruigómez, Estel Plana, Alicia Gilsenan, et al.
Paediatric and Perinatal Epidemiology
|
July 17, 2004
The Walker Project: a longitudinal study of 48,000 children born 1952-1966 (aged 36-50 years in 2002) and their families
Gillian Libby, Anne Smith, Neil F McEwan, et al.
BMJ Open
|
August 9, 2015
Prevention And Treatment of Hypertension With Algorithm-based therapy (PATHWAY) number 2: protocol for a randomised crossover trial to determine optimal treatment for drug-resistant hypertension
Bryan Williams, Thomas M MacDonald, Mark Caulfield, et al.
BMJ Open
|
February 11, 2016
Methods of a large prospective, randomised, open-label, blinded end-point study comparing morning versus evening dosing in hypertensive patients: the Treatment In Morning versus Evening (TIME) study
David A Rorie, Amy Rogers, Isla S Mackenzie, et al.
BMC Medicine
|
February 3, 2021
Impact of multiple cardiovascular medications on mortality after an incidence of ischemic stroke or transient ischemic attack
Tian-Tian Ma, Ian C K Wong, Cate Whittlesea, et al.
BMC Medicine
|
September 12, 2021
Correction to: Impact of multiple cardiovascular medications on mortality after an incidence of ischemic stroke or transient ischemic attack
Tian-Tian Ma, Ian C K Wong, Cate Whittlesea, et al.
Page
of 16